跳至主要内容
临床试验/NCT03104907
NCT03104907已完成不适用

Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer

Rigshospitalet, Denmark2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2017年3月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
15
试验地点
2
主要终点
Ability to void spontaneously

研究概览

简要总结

The aim of this study is to investigate the safety and efficacy of prostatic artery embolization of patients with recurrent symptoms secondary to locally advanced prostatic cancer including pelvic pain, bleeding or need for permanent urinary catheter who are unfit for or refuse surgical treatment.

详细描述

This is a prospective study investigating the safety and efficacy of PAE for patients with prostate cancer who suffers from acute urinary retention, severe LUTS and/or recurrent complications such as haematuria.

Our hypothesis is that PAE will eliminate the need for indwelling catheter and improve IPSS and QoL 12 months post-procedure.

1, and 6 months follow-up.

Main outcome Ability to void after removal of indwelling catheter

Secondary outcomes International Prostate Symptom Score (IPSS) Quality of Life (QoL) International Index of Erectile Function (IIEF) Prostate volume Peak void flow (Qmax) Post-void residual (PVR) Classify complications according to Society of Interventional Radiology (SIR) guidelines for reporting Prostate-specific antigen (PSA)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
Male
接受健康志愿者

入选标准

  • Indwelling catheter secondary to locally advanced prostate cancer (PCa) or
  • Moderate-severe Obstructive LUTS secondary to PCa
  • Unsuitable for or refuse surgery

排除标准

  • Bladder dysfunction(and known neurological conditions affecting bladder function)
  • Urethral strictures
  • Bladder neck contracture
  • Known sphincter anomalies
  • Big bladder diverticulum or stones
  • Kidney insufficiency (eGFR < 45)
  • Coagulation disturbances
  • Severe atheromatous or tortuosity of arteries
  • Allergy to contrast medium
  • Unable to undergo MR imaging
  • Bladder malignancy

研究组 & 干预措施

Prostatic Artery Embolization

Experimental

Embolization of the prostatic arteries to induce necrosis and a reduction of the prostate volume.

干预措施: Prostatic Artery Embolization (Procedure)

结局指标

主要结局

Ability to void spontaneously

时间窗: 1 months

The ability to void after removal of the indwelling catheter

次要结局

  • IPSS(1, 6 months)
  • IIEF(1, 6 months)
  • PV(1, 6 months)
  • PVR(1, 6 months)
  • Qmax(1, 6 months)
  • PSA(1, 24-hours, 6 months)
  • QoL(1, 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brian Malling

MD

Rigshospitalet, Denmark

研究点 (2)

Loading locations...

相似试验

Prostatic Artery Embolization for Obstructive... | 临床试验